Abciximab - Wikipedia
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly …
Abciximab (intravenous route) - Mayo Clinic
2025年2月1日 · Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A …
Abciximab: Uses, Interactions, Mechanism of Action | DrugBank ...
2005年6月13日 · Abciximab is a monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention. Abciximab is a Fab fragment of …
Abciximab: Indications, Side Effects, Warnings - Drugs.com
2024年3月8日 · It is used to lower the number of heart attacks in patients who have unstable angina or mild heart attacks. What do I need to tell my doctor BEFORE I take Abciximab? If …
ReoPro: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年8月23日 · ReoPro is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A …
Abciximab Advanced Patient Information - Drugs.com
Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A heart attack …
Abciximab injection - Cleveland Clinic
ABCIXIMAB (ab SIX i mab) prevents blood clots during episodes of chest pain or a heart attack. It may be used during heart surgery.
Abciximab: Side Effects, Uses, Dosage, Interactions, Warnings
Abciximab is a prescription medication used for the prevention of unstable angina or cardiac complications in people undergoing PCI.